Robert Garver
Pulmonary Disease · Andalusia, ALNPI 1639113707
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,465 of the $9,700 with a category attached, or 66.6%. 11 manufacturers reported payments, led by Novartis at 24.5% of the total.
Across 103 payments — averaging $94.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Astrazeneca UK Limited$2K
- Eli Lilly$2K
- Bayer$1K
- Modernatx, Inc.$1K
- GSK$240
- plus $350 from 5 others
Across 585 payments — averaging $7798.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$1.8M
- Genentech, Inc.$1.2M
- AstraZeneca$393K
- Chiesi USA, Inc.$360K
- Boehringer Ingelheim$276K
- Hoffmann-la Roche Limited$250K
- plus $255K from 8 others
What the payments were for
- Travel & lodging$6,46567%
- Food & beverage$3,23533%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $2,373 |
| Astrazeneca UK Limited | 14 | $2,057 |
| Eli Lilly | 19 | $1,904 |
| Bayer | 9 | $1,430 |
| Modernatx, Inc. | 4 | $1,346 |
| GSK | 16 | $240 |
| Boehringer Ingelheim | 12 | $196 |
| Sunovion Pharmaceuticals Inc. | 5 | $57 |
| AstraZeneca | 3 | $44 |
| Grifols USA, LLC | 2 | $36 |
| Genentech, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QBW251$665
How this compares
$9,700 in reported general payments places this provider in the 75th percentile of 215 pulmonary disease providers in Alabama.
Other pulmonary disease in Andalusia
- William SaliskiMontgomery$257K
- Emily RehbergSylacauga$166K
- Tejaswini KulkarniBirmingham$134K
- Adrian DivittorioMobile$100K
- Luther CorleyHuntsville$86K
- Peter LutzMobile$63K
- Mohammad AzamTuscaloosa$58K
- Amanda DenhamBirmingham$45K
- Darryle BullardCullman$30K
- Bryan GarciaBirmingham$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.